SYNTHON BIOPHARMACEUTICALS B.V.
Patent Owner
Stats
- 8 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Feb 13, 2018 most recent publication
Details
- 8 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 406 Total Citation Count
- Jan 09, 1998 Earliest Filing
- 25 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9580501 Anti-TNF alpha monoclonal secretory IgA antibodies and methods for treating inflammatory diseasesDec 14, 12Feb 28, 17[A61K, C12N, C07K]
9573996 Monoclonal antibodies to human proinflammatory cytokines and methods for treating inflammatory diseasesDec 14, 12Feb 21, 17[A61K, C12N, C07K]
9427480 Duocarmycin ADCs for use in treatment of endometrial cancerSep 18, 15Aug 30, 16[A61K, C07D, C07K]
9421278 Duocarmycin ADCS showing improved in vivo antitumor activitySep 18, 15Aug 23, 16[A61K, C07D, C07K]
8716557 Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in plantsJan 17, 07May 06, 14[C07H, C12N, A01H]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0014,525 DUOCARMYCIN ADCS SHOWING IMPROVED IN VIVO ANTITUMOR ACTIVITYAbandonedJul 21, 16Jan 19, 17[A61K, C07K]
2014/0216,118 Compositions and Methods for Making and Biocontaining Auxotrophic Transgenic PlantsAbandonedJun 13, 12Aug 07, 14[C12N]
2012/0258,491 EXPRESSION OF BIOLOGICALLY ACTIVE POLYPEPTIDES IN DUCKWEEDAbandonedSep 14, 11Oct 11, 12[C12P, C12N, A01H]
2012/0220,015 COMPOSITIONS AND METHODS FOR PRODUCTION OF AGLYCOSYLATED PLASMINOGENAbandonedMay 26, 10Aug 30, 12[C12N, A01H]
2012/0190,004 METHODS AND COMPOSITIONS FOR THE CRYOPRESERVATION OF DUCKWEEDAbandonedJun 22, 10Jul 26, 12[A01N]
8182803 C-terminally truncated interferon alpha variantsExpiredMay 11, 11May 22, 12[A61K, C12P, C12N, C07K]
8022270 Expression of biologically active polypeptides in duckweedExpiredSep 30, 03Sep 20, 11[C12N, A01H]
8017836 Expression of plasminogen and microplasminogen in duckweedExpiredDec 22, 09Sep 13, 11[C12N, A01H]
7959910 C-terminally truncated interferon alpha variantsExpiredApr 16, 04Jun 14, 11[A61K, C07H, C12P, C12N, C07K]
7884264 Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in duckweed plantsExpiredJan 17, 07Feb 08, 11[C07H, C12N, A01H]
2010/0303,808 HUMANIZED ANTI-CD20 ANTIBODIES AND METHODS OF USEAbandonedMar 09, 10Dec 02, 10[A61K, C07H, C12N, A61P, C07K]
2010/0209,966 ASEPTIC BIOREACTOR SYSTEM FOR PROCESSING BIOLOGICAL MATERIALSAbandonedFeb 18, 10Aug 19, 10[C12P, C12M]
7659445 Expression of plasminogen and microplasminogen in duck weedExpiredFeb 11, 05Feb 09, 10[C12N]
7622573 Expression control elements from the lemnaceae familyExpiredJan 16, 07Nov 24, 09[C07H, C12N, A01H]
2009/0060,921 GLYCAN-OPTIMIZED ANTI-CD20 ANTIBODIESAbandonedMay 05, 08Mar 05, 09[A61K, C12N, A61P, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.